Who Pays My Doctor?

Healthcare provider profile · identity verified

Daniel Kim, M.D., M.B.A.

Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology · FAIRFAX, VA · NPI 1437507274

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel Kim, M.D., M.B.A. received $261,180.35 in general payments during 2025 across 300 reported records.

Teleflex LLC accounted for 49.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 15 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$261,180.35

300 reported records · 15 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
Teleflex LLC Unresolved — no canonical attribution shown $128,496.4349.2%912025
BIOPROTECT MEDICAL, INC. Unresolved — no canonical attribution shown $62,426.1523.9%1312025
Novocure Inc. Unresolved — no canonical attribution shown $39,356.5115.1%182025
GT Medical Technologies, Inc Unresolved — no canonical attribution shown $21,831.018.4%362025
IZI Medical Products, LLC Unresolved — no canonical attribution shown $4,000.001.5%12025
Novartis Pharmaceuticals Corporation Unresolved — no canonical attribution shown $3,300.001.3%12025
Theragenics Corporation Unresolved — no canonical attribution shown $482.940.2%82025
Telix Pharmaceuticals Unresolved — no canonical attribution shown $480.260.2%32025
Boston Scientific Corporation Unresolved — no canonical attribution shown $201.420.1%22025
AngioDynamics, Inc. Unresolved — no canonical attribution shown $161.010.1%22025
Janssen Scientific Affairs, LLC Unresolved — no canonical attribution shown $118.650.1%12025
Longeviti Neuro Solutions INC Unresolved — no canonical attribution shown $105.480.0%12025
Siemens Medical Solutions USA, Inc. Unresolved — no canonical attribution shown $94.270.0%22025
Myriad Genetic Laboratories, Inc. Unresolved — no canonical attribution shown $78.350.0%22025
Philips North America LLC Unresolved — no canonical attribution shown $47.870.0%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$134,300.0032
Consulting Fee$95,690.0036
Food and Beverage$19,356.11197
Travel and Lodging$10,569.2433
Honoraria$1,265.002

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
BARRIGEL
Normalized: barrigel		 Device Teleflex LLC $127,756.43 90 2025
Source payment records
BIOPROTECT BALLOON IMPLANT SYSTEM
Normalized: bioprotect balloon implant system		 Device BIOPROTECT MEDICAL, INC. $62,426.15 131 2025
Source payment records
Optune Gio
Normalized: optune gio		 Device Novocure Inc. $30,602.23 13 2025
Source payment records
GammaTile
Normalized: gammatile		 Device GT Medical Technologies, Inc $21,831.01 36 2025
Source payment records
PLUVICTO
Normalized: pluvicto		 Drug Novartis Pharmaceuticals Corporation $3,300.00 1 2025
Source payment records
UROLIFT
Normalized: urolift		 Device Teleflex LLC $3,102.81 7 2025
Source payment records
ILLUCCIX
Normalized: illuccix		 Drug Telix Pharmaceuticals $480.26 3 2025
Source payment records
Optune Lua (NovoTTF-200T)
Normalized: optune lua novottf 200t		 Device Novocure Inc. $325.34 3 2025
Source payment records
SpaceOAR VUE System - 10mL
Normalized: spaceoar vue system 10ml		 Device Boston Scientific Corporation $201.42 2 2025
Source payment records
NANOKNIFE
Normalized: nanoknife		 Device AngioDynamics, Inc. $161.01 2 2025
Source payment records
ERLEADA
Normalized: erleada		 Drug Janssen Scientific Affairs, LLC $118.65 1 2025
Source payment records
ClearFit
Normalized: clearfit		 Device Longeviti Neuro Solutions INC $105.48 1 2025
Source payment records
TrueBeam
Normalized: truebeam		 Device Siemens Medical Solutions USA, Inc. $94.27 2 2025
Source payment records
PROLARIS
Normalized: prolaris		 Device Myriad Genetic Laboratories, Inc. $78.35 2 2025
Source payment records
Disease Management Solutions Equipment Undivided
Normalized: disease management solutions equipment undivided		 Device Philips North America LLC $47.87 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

BrandGenericClaimsBeneficiaries
Tamsulosin HclTamsulosin Hcl3919

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $261,180.35 · 300 records Teleflex LLC BARRIGEL, BIOPROTECT BALLOON IMPLANT SYSTEM, ClearFit, Disease Management Solutions Equipment Undivided, ERLEADA, GammaTile, ILLUCCIX, NANOKNIFE, Optune Gio, Optune Lua (NovoTTF-200T), PLUVICTO, PROLARIS, SpaceOAR VUE System - 10mL, TrueBeam, UROLIFT — —
2024 — — — — Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error